Cargando…
Case Report: Neonatal Unexplained HUS Treated With Complement Inhibitor Eculizumab
Background: Hemolytic uremic syndrome (HUS) is rare in neonates. It is probably an under-recognized condition in the early postnatal period as it presents similarly to the most common perinatal asphyxia and to differentiate the two conditions is challenging. We describe the clinical presentation of...
Autores principales: | Kelen, Dorottya, Chiodini, Benedetta, Godart, Valérie, Adams, Brigitte, Stordeur, Patrick, Ismaili, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930232/ https://www.ncbi.nlm.nih.gov/pubmed/33681093 http://dx.doi.org/10.3389/fped.2020.579607 |
Ejemplares similares
-
Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing
por: Benoit, Stefanie W., et al.
Publicado: (2022) -
Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1
por: Chiodini, Benedetta, et al.
Publicado: (2022) -
The Struggling Odyssey of Infantile Primary Hyperoxaluria
por: Guillaume, Adrien, et al.
Publicado: (2021) -
Remission of aHUS neurological damage with eculizumab
por: Ávila, Ana, et al.
Publicado: (2015) -
Eculizumab and aHUS: Spotlight on Patient-Centered Care
por: Rafat, Cédric, et al.
Publicado: (2020)